Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Decline in Ocular Toxoplasmosis over 40 Years at a Tertiary Referral Practice in the United States.

Hou JH, Patel SS, Farooq AV, Qadir AA, Tessler HH, Goldstein DA.

Ocul Immunol Inflamm. 2016 Nov 28:1-7. doi: 10.1080/09273948.2016.1246665. [Epub ahead of print]

PMID:
27892751
2.

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2016 Apr;164:29-36. doi: 10.1016/j.ajo.2015.12.028. Epub 2015 Dec 31.

3.

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9. doi: 10.1016/j.ajo.2015.09.017. Epub 2015 Sep 18.

4.

Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.

Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group.

Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7.

5.
6.

Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.

Ophthalmology. 2015 Oct;122(10):1967-75. doi: 10.1016/j.ophtha.2015.06.042. Epub 2015 Aug 20.

7.

Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD.

Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5.

8.

Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature.

Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan CC, Brown DM, Thorne JE, Wang R, Cunningham ET Jr.

Ocul Immunol Inflamm. 2014 Jun;22(3):175-82. doi: 10.3109/09273948.2013.866256. Epub 2014 Mar 21. Review.

9.

Long-term, drug-free remission of sympathetic ophthalmia with high-dose, short-term chlorambucil therapy.

Patel SS, Dodds EM, Echandi LV, Couto CA, Schlaen A, Tessler HH, Goldstein DA.

Ophthalmology. 2014 Feb;121(2):596-602. doi: 10.1016/j.ophtha.2013.09.009. Epub 2013 Oct 25.

PMID:
24572676
10.

Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.

Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ophthalmology. 2013 Sep;120(9):1852-9. doi: 10.1016/j.ophtha.2013.01.069. Epub 2013 May 21.

11.

Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.

Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group.

Ophthalmology. 2013 Aug;120(8):1571-9. doi: 10.1016/j.ophtha.2013.01.025. Epub 2013 Apr 16.

12.

Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity.

Patel SS, Saraiya NV, Tessler HH, Goldstein DA.

JAMA Ophthalmol. 2013 Jun;131(6):752-8. doi: 10.1001/jamaophthalmol.2013.71.

PMID:
23579549
13.

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.

Suhler EB, Lowder CY, Goldstein DA, Giles T, Lauer AK, Kurz PA, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Tessler HH, Smith JR, Rosenbaum JT.

Br J Ophthalmol. 2013 Apr;97(4):481-6. doi: 10.1136/bjophthalmol-2012-302292. Epub 2013 Feb 2.

PMID:
23376607
14.

Bilateral simultaneous-onset nongranulomatous acute anterior uveitis: clinical presentation and etiology.

Birnbaum AD, Jiang Y, Vasaiwala R, Tessler HH, Goldstein DA.

Arch Ophthalmol. 2012 Nov;130(11):1389-94. doi: 10.1001/archophthalmol.2012.2006.

PMID:
22777605
15.

Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease.

Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA.

Am J Ophthalmol. 2012 Jul;154(1):72-7. doi: 10.1016/j.ajo.2012.01.016. Epub 2012 Mar 30.

16.

Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ocul Immunol Inflamm. 2012 Apr;20(2):104-12. doi: 10.3109/09273948.2011.647228.

17.

Behçet uveitis in the American midwest.

Saleh OA, Birnbaum AD, Tessler HH, Goldstein DA.

Ocul Immunol Inflamm. 2012 Feb;20(1):12-7. doi: 10.3109/09273948.2011.630550. Erratum in: Ocul Immunol Inflamm. 2012 Apr;20(2):149.

PMID:
22324896
18.

Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT; Multicenter Uveitis Steroid Treatment-MUST Trial Research Group.

Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1169-76. doi: 10.1167/iovs.11-8259. Print 2012 Mar.

19.

Chronic anterior uveitis in common variable immunodeficiency.

Oltra EZ, Morris C, Birnbaum AD, Tessler HH, Goldstein DA.

Ocul Immunol Inflamm. 2011 Dec;19(6):448-9. doi: 10.3109/09273948.2011.625136.

PMID:
22106916
20.

Vogt-Koyanagi-Harada syndrome in a 6-year-old Hispanic boy.

Hernandez C, LePoole C, Tessler HH.

Pediatr Dermatol. 2012 Mar-Apr;29(2):191-4. doi: 10.1111/j.1525-1470.2011.01571.x. Epub 2011 Oct 13. Review.

PMID:
21995870

Supplemental Content

Loading ...
Support Center